Quantcast

Latest Interventional cardiology Stories

2014-06-27 08:25:53

PLEASANTON, Calif., June 27, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that its CE Mark Clinical Trial for HeartMate III(TM) commenced with the first patient implanted with this new device. "We are pleased to reach this significant clinical milestone with an important pipeline product," said Gary F. Burbach, President and Chief Executive...

2014-06-25 23:08:55

ResearchMoz.us include new market research report "United States Interventional Cardiology Market Outlook to 2020" to its huge collection of research reports. Full report at http://www.researchmoz.us/united-states-interventional-cardiology-market-outlook-to-2020-report.html. Albany, NewYork (PRWEB) June 25, 2014 United States Interventional Cardiology Market Outlook to 2020 Summary GlobalDatas new report, "United States Interventional Cardiology Market Outlook to...

2014-06-24 08:32:14

Pioneering Angiogenic Gene Therapy for the Potential Treatment of Millions of Patients with Heart Disease Worldwide SAN DIEGO, June 24, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) will report today at the Biotechnology Industry Organization's 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx(®) Ad5FGF-4, Cardium Therapeutics' angiogenic gene...

2014-06-17 23:03:51

The North American interventional cardiology devices market study covers the surgical and diagnostic devices market for angioplasty, aneurysm repair, and deep vein thrombosis procedures. http://www.marketsandmarkets.com/Market-Reports/north-american-interventional-cardiology-peripheral-vascular-devices-market-138691746.html (PRWEB) June 17, 2014 The "North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent...

2014-06-17 08:30:12

Veteran Medical Device Executive To Lead Transcatheter Valve Company Through Clinical Trial Phase MAPLE GROVE, Minn., June 17, 2014 /PRNewswire/ -- HLT, Inc., a medical device company developing leading-edge transcatheter aortic valve replacement (TAVR) therapy, today announced the addition of Kevin Bassett as general manager. In his new role, Bassett will lead the development and achievement of HLT's strategic business objectives and milestones in collaboration with parent company,...

2014-06-17 08:29:31

DUBLIN, June 17, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/h8c9j9/north_american) has announced the addition of the "North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon, Stent, Catheter, IVC Filter, Endovascular Stent Graft - Forecast to 2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The North American interventional cardiology devices market is expected to...

2014-06-16 23:02:35

ReportsnReports.com adds “Canada Cardiovascular Procedures Outlook to 2020” & Mexico Cardiovascular Procedures Outlook to 2020” to its store. Dallas, Texas (PRWEB) June 16, 2014 Canada Cardiovascular Procedures Outlook to 2020 "Canada Cardiovascular Procedures Outlook to 2020," provides key procedures data on the Canada Cardiovascular Procedures. The report provides procedure volumes within market categories Cardiac Assist Procedures, Cardiovascular Surgery,...

2014-06-15 08:21:09

LONDON, June 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Drug-eluting Stent Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/prescription_drugs/global_drug_eluting_stents_market.htmlTechNavio's analysts forecast the Global Drug-eluting Stent (DES) market to grow at a CAGR of 5.79 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of CVD. The Global...

2014-06-12 08:30:38

FRAMINGHAM, Mass., June 12, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Wells Fargo Healthcare Conference at 4:40 p.m. EDT on Tuesday, June 17, 2014. The conference is being held June 17-18 at the InterContinental Boston. A live webcast of...

2014-06-12 08:28:30

ZWOLLE, The Netherlands, June 12, 2014 /PRNewswire/ -- Randomized Evaluation of short-term DUal antiplatelet therapy in patients with acute coronary syndrome treated with the COMBOTM Dual-Therapy StEnt The Principal Investigators of the REDUCE trial announce the enrolment of the first patient in the REDUCE trial with the OrbusNeich COMBO Dual Therapy Stent at Isala Hospital, Zwolle, the Netherlands. According to the local PI and treating physician, Doctor E....


Latest Interventional cardiology Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »
Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related